IMI Tinkered, etc

[tjh290633]

This morning IMI had a big jump in price, and it was already nudging at the limit where I automatically trim a holding back. Consequently I sold 25% of my holding at 1,425p, dropping it from pole position to 10th ranked by value. With dividends accumulated to date, I had enough cash to top up three holdings, based on last night's rankings. Accordingly I added 16% to my holding of GSK, raising that from 23rd to 11th place, 17% to my holding of MKS, raising that from 27th to 16th place, and 20% to my holding of UU., raising that from 33rd to 25th place.

Now the top up table looks like this:

Top-up          Income                     Cost                
Rank     EPIC   Rank     EPIC   % Income   Rank   Epic   % Cost
     1   SSE         1   TW.       5.83%      1   GSK     4.45%
     2   NG.         2   RDSB      4.68%      2   MKS     4.29%
     3   IMB         3   MARS      4.48%      3   PSON    4.06%
     4   LLOY        4   SSE       4.29%      4   RDSB    4.06%
     5   MKS         5   BP.       4.14%      5   SGRO    4.05%
     6   VOD         6   GSK       4.09%      6   LLOY    4.02%
     7   ADM         7   MKS       4.00%      7   MARS    3.95%
     8   UU.         8   RIO       3.76%      8   CLLN    3.90%
     9   BT.A        9   VOD       3.70%      9   SSE     3.81%
    10   MARS       10   BT.A      3.66%     10   AV.     3.81%
    11   S32        11   LGEN      3.62%     11   BLT     3.59%
    12   BLT        12   ADM       3.58%     12   LGEN    3.47%

As can be seen, GSK and MKS advance to the top of the share of cost list and are disqualified from further top up as it is. Likewise, TW., RDSB, MARS and SSE are disqualified because of share of income. That makes NG., IMB and LLOY the next candidates for topping up.

The portfolio, ranked by weight, is now:

Rank   EPIC   Weight
   1   SGRO    3.82%
   2   RIO     3.77%
   3   RDSB    3.67%
   4   WMH     3.56%
   5   TW.     3.38%
   6   AV.     3.27%
   7   AZN     3.26%
   8   BP.     3.15%
   9   SMDS    3.14%
  10   IMI     3.11%
  11   GSK     3.04%
  12   MARS    3.03%
  13   CPG     3.03%
  14   LGEN    2.98%
  15   DGE     2.96%
  16   MKS     2.88%
  17   BT.A    2.85%
  18   VOD     2.82%
  19   BATS    2.81%
  20   ADM     2.80%
  21   BLND    2.72%
  22   SSE     2.71%
  23   ULVR    2.60%
  24   BA.     2.59%
  25   UU.     2.56%
  26   IMB     2.53%
  27   TATE    2.48%
  28   RB.     2.46%
  29   LLOY    2.42%
  30   BLT     2.40%
  31   PSON    2.32%
  32   NG.     2.31%
  33   KGF     2.29%
  34   S32     1.46%
  35   TSCO    1.44%
  36   INDV    1.19%
  37   CLLN    0.18%

It will be towards the end of February before I have suficient accumulated dividends to make a further top up.

TJH

[Arborbridge]

Well, it's nice to see someone has the courage of his convictions in buying more MKS! - you're not alone, as the price hasn't continued falling, but has come back.

MKS and GNK are 3 and 4 in my top-up table but I may not be in a position to top up until next month.

Arb.